Zhou et al. observed higher levels of serum ferritin and CRP in patients with lung cancer, and regarding the non-small cell lung cancer (NSCLC) subtype, they measured higher values of these parameters in patients with adenocarcinoma compared to those with squamous cell carcinoma [38]. This evidence concerns the gene CRP and squamous cell carcinoma.